Sampre Nutritions Ltd

Sampre Nutritions Limited: Trading Window Closed from 01 October 2026 till 48 hours after the declaration of unaudited standalone and consolidated financial results for the second quarter of FY 2026-27 (quarter ended 30 September 2026).

Capital Action

• Board approved preferential allotment on conversion of unsecured loan.
• Allotment size: 1,770,710 equity shares at INR 42 per share.
• Face value INR 5; premium INR 37.
• Allottees: Brahma Gurbani and Meera Gurbani.
• Aggregate value: INR 7,43,69,820.
• Pursuant to members' special resolution dated 10 December 2025.
• Post-allotment shareholding: Brahma Gurbani 7.48%, Meera Gurbani 3.47%.
• Board meeting date: 25 September 2026.

Key details

• In-principle approval from BSE for issue of equity shares to promoter and promoter group on a preferential basis.
• Equity shares to be issued via conversion of unsecured loans.
• Allottees: promoter and promoter group category.
• Date of approval communicated: 28 August 2026.
• Purpose: convert unsecured loans into equity for promoter group.
• Nature of consideration: conversion of loans into equity.
• Approvals required: BSE in-principle approval obtained.

AGM Details

• 35th AGM scheduled for 04 September 2026 at 11:00 IST via VC/OAVM.
• Cut-off date for remote e-voting and attendance is 28 August 2026.
• Remote e-voting opens 01 September 2026 at 09:00 IST.
• Remote e-voting closes 03 September 2026 at 05:00 PM IST.

Access to AGM Materials

• Annual report for FY 2025-26 accessible on company and BSE websites.
• Notice and AGM materials accessible via QR code and provided links.

AGM Details

• AGM scheduled for 04 Sep 2026 at 11:00 AM IST via VC/OAVM.
• Notice dated 14 August 2026.
• Corrigendum issued for typographical errors in scrutinizer appointment dates.
• Corrected Annual Report 2025-26 dispatched to members and uploaded to the company website.

Financial highlights

• Standalone total income 4,405.76 L; PAT 386.56 L; Basic EPS 1.84; Diluted 2.73.
• Consolidated total income 4,377.92 L; PAT 307.68 L; EPS 2.18.
• Dividend: no dividend recommended for 2025-26.
• Total assets 12,697.88 L; Total equity 10,023.76 L.
• Equity share capital ended at 95,008,913 shares (Rs 4,750.45 L).
• Net debt 2,667.86 L; gearing 0.21x.
• Standalone cash flow: operating -94.10 L; investing -275.42 L; financing 370.13 L; net change 0.62 L.

Capital actions

• 840,000 convertible warrants converted to equity; 550k on 12-09-2025; 290k on 25-09-2025.
• Share capital increased to Rs 4,750.45 L via 74,002,058 new shares.
• Share sub-division: Rs 10 to Rs 5 per share on 14 Nov 2025.
• Bonus issue: 43,693,710 shares issued 1:1 on 14 Nov 2025.
• FCCBs converted: 7,621,493 equity shares; 2 FCCBs remain outstanding.
• Record date for sub-division: 14 November 2025.

Governance & board changes

• Board: six directors; two Executive, four Independent; one Woman Director, Vanita Khatter.
• Vinay Kumar Verma ceased as Independent Director on 19 August 2025.
• Pradeep Narendra Poddar appointed Additional Director on 13 February 2026; approved 10 May 2026.
• Audit Committee: four members; Chair Nagaraju Kanneganti.
• Nomination & Remuneration Committee: four Independent Directors; Chair Vanita Khatter.
• Stakeholders' Relationship Committee: four Independent Directors; Chair Kireet Modi.

Subsidiaries and group

• Subsidiaries: Sampre Nutritions FZCO (Dubai) and Sampre Nutritions Holding Limited (UK).
• Form AOC-1 Annexure 4 provides salient features of subsidiaries and group.

Audit & compliance

• Statutory auditor: N G Rao & Associates; Secretarial auditor: Neelu Goyal & Associates.
• MD & CFO certifications attached to the annual report.
• MR-3 secretarial audit reported a modified opinion for 2024-25; actions planned.
• Internal financial controls are adequate and operating effectively.
• Audit fees total 5.00 L: 4.50 L statutory; 0.20 L certifications; 0.30 L others.

CSR & sustainability

• CSR not applicable; no CSR policy or committee for 2025-26.
• Company highlights ongoing sustainability and governance focus.

Related party transactions

• Arm's-length related party transactions; notable items include director remuneration.
• Balances receivable/payable with related parties: Royes 953.43 L; directors 900.09 L; 80.57 L.

Risks & outlook

• Outlook: long-term prospects positive; margins pressured by raw material costs; focus on efficiency.
• Management focuses on capital allocation, risk management, and cash flow discipline.

AGM Details

• Date and time: 04 September 2026 at 11:00 IST, via VC/OAVM.
• Cut-off for remote voting/attendance: 28 August 2026.
• Remote e-voting period: 01 Sep 2026 09:00 IST to 03 Sep 2026 05:00 PM IST.

Key Resolutions

• Item 1 (Ordinary): Adopt audited financial statements for year ended 31 March 2026.
• Item 2 (Ordinary): Reappoint Vishal Ratan Gurbani as Director on rotation.
• Item 3 (Special): Remuneration revision for Vishal Ratan Gurbani to ₹60 L, effective 01 Apr 2026.

Voting Results

• Outcome: to be declared; subject to requisite votes.

Dividend

• No dividend proposal mentioned.

Director Changes

• Reappointment of Vishal Ratan Gurbani as Director (Whole-Time Director) on rotation.

Auditors

• No auditor appointments or changes disclosed in this chunk.

Material Related Party Transactions

• No material related party transactions disclosed.

Other Approvals

• Board authorized to implement remuneration revision and execute related documents.

AGM notice and remuneration

• Approved notice for the 35th AGM on 04 Sep 2026 at 11:00 IST via VC/OAVM.
• Remuneration for Vishal Gurbani increased to INR 60 Lakh, with effect from 01-Apr-2026, subject to AGM approval.
• Not a fresh appointment; other terms of Vishal Gurbani's appointment unchanged.

Q1 2026-27 unaudited financial results

• Approved standalone and consolidated unaudited results for Q1 FY 2026-27 (quarter ended 30 June 2026).
• Results reviewed by Audit Committee and Board; subject to statutory auditors' review.